Navigation Links
Next generation data analysis for next generation sequencing data
Date:7/2/2008

Genomatix Software, a company with an outstanding track record in the analysis of genomic data generated by high throughput technologies, announced availability of the Genomatix Genome Analyzer today. The Genomatix Genome Analyzer (GGA) is the first integrated hardware / software solution for in-depth analysis of data generated by next generation sequencing (NGS) devices as provided by Illumina, Roche (454), Applied Biosystems (SOLiD) and Helicos.

Terabytes of locally installed data integrated with Genomatix powerful analysis technology facilitate easy extraction of relevant biological knowledge from mammalian ChIP-seq and transcriptome studies.

A typical analysis of a ChIP-seq experiment with 10 million reads takes only 2 hours. Results contain all important information: clustered and classified enriched regions, transcription factor (TF) over-representation and TF associations. In addition, genome-wide correlations with genomic features as well as meta-analysis with genome-wide chromatin modification, methylation state, expression levels or any data derived by other NGS experiments can be added with a few mouse clicks. Identification of phylogenetically conserved functional elements add another dimension of analytic power.

Transcriptome studies result in normalized and quantified expression values and allow for immediate identification of new transcriptional units and splice variants, all integrated and visualized in today's most complete genome annotation ElDorado, which is built into the GGA.

The GGA is driven by an easy-to-use, integrated browser based interface. Alternatively all database structures, scripts and tools are open and accessible to the bio-informatics specialist for re-arrangement or integration of own procedures.

"I am really excited about the power and possibilities arriving with all this new technology!", says Klaus May, Chief Business Officer of Genomatix. "All this flood of data arriving from NGS now reinforce our developments over the last decade. We have a unique knowledge base which together with our leading technology lifts biological understanding to the next level. Further proof comes from a multitude of projects and a series of scientific publications to be out shortly. The GGA empowers the researcher beyond comparison. All you need, in one box on your desk." he concludes.


'/>"/>

Contact: Klaus May
may@genomatix.de
498-959-9766
Genomatix Software GmbH
Source:Eurekalert  

Related medicine news :

1. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
2. MSAs Next-Generation Breathing Apparatus for Firefighters First to Receive Full NFPA Approval
3. Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration
4. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
5. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
6. Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2(TM) Treatment System for Fibroadenomas
7. Smithfield(R) LEAN GENERATION(R) Announces DELI FOR THE CURE(TM)
8. Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics
9. $37 million financing for company based on macular degeneration research
10. Model to study age-related macular degeneration could pave way for better treatment
11. Starion Instruments Launches Next-Generation Tissue Ligating Shears at the American College of Surgeons Clinical Congress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Next generation data analysis for next generation sequencing data
(Date:7/21/2017)... ... 2017 , ... The Ellis Agency, an eastern Georgie provider of insurance management ... wide charity event with the goal of bringing in support for epilepsy patients in ... with epilepsy, recently launched a charity campaign of her own by donating her birthday ...
(Date:7/21/2017)... ... , ... Fresh Wave® IAQ today announced the launch of its innovative ... at the APPA 2017 Annual Conference and Exhibition in Booth #414. , ... the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air & Fabric Liquid ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm ... the contents of its ginger ale for allegedly containing no ginger. Dr. Pepper produces ... Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how ... their shoes,” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. ... on Kickstarter on Monday, July 21st. , The kit uses colorful, engaging and ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... cruciate ligament (ACL) offer patients improved quality of life five years after injury, ... Medicine’s Annual Meeting in Toronto, Ontario, Canada. The study followed patients for ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
Breaking Medicine Technology: